Free Trial
→ Trump’s issues shocking Executive Order on U.S. Dollar (From Banyan Hill Publishing) (Ad)tc pixel
NASDAQ:SEER

Seer Q3 2026 Earnings Date & Estimates

Seer logo
$2.19 +0.02 (+0.92%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$2.18 0.00 (-0.23%)
As of 10/9/2026 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Seer is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Seer in Q3 2026

Seer is expected to post earnings of -$0.26 per share on revenue of $4.15 million. In the same quarter a year earlier Seer reported -$0.32 per share on revenue of $4.12 million. Seer last reported on August 11, 2026, posting -$0.31 per share and missing the -$0.27 consensus estimate. Seer has beaten the consensus EPS estimate in 5 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.26
Expected Revenue
$4.15 million
Prior-Year EPS
-$0.32
Prior-Year Revenue
$4.12 million
Expected Revenue Growth
+0.7%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.31 (Missed by -$0.04)
Last Quarter Revenue
$3.10 million
EPS Beat Rate
5 of last 8 quarters

Prepare for the Q3 2026 Call

Seer Q3 2026 Earnings FAQ

Seer (NASDAQ:SEER) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes.

Seer's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Seer to post earnings of -$0.26 per share for Q3 2026.

The consensus revenue estimate for Seer is $4.15 million for Q3 2026.

Seer Earnings Headlines

Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026
September 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/23/3367349/0/en/seer-and-nanyang-technological-university-to-present-early-findings-from-landmark-precise-sg100k-proteomics-study-at-hupo-2026.html
Seer CFO David Horn Steps Down
September 21, 2026  |  rttnews.comhttps://www.rttnews.com/3692676/seer-cfo-david-horn-steps-down.aspx
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.tc pixel
October 10 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Seer CFO David Horn to Resign
September 21, 2026  |  marketscreener.comM
Seer CFO David Horn to Depart
September 21, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/seer-cfo-david-horn-to-depart-c589670f
Seer Announces CFO Transition As Horn Steps Down And Endweiss Appointed, Effective Oct. 1 '26
September 21, 2026  |  rttnews.comhttps://www.rttnews.com/3692645/seer-announces-cfo-transition-as-horn-steps-down-and-endweiss-appointed-effective-oct-1-26.aspx
See More Seer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email.

About Seer

Seer (NASDAQ:SEER) is a life sciences company that develops technologies for large-scale protein analysis, or proteomics. Its platform is designed to help researchers study the proteins present in biological samples and generate insights into disease biology, drug discovery and the development of precision medicine.

The company’s principal offering is the Proteograph Product Suite, which combines proprietary nanoparticle technology with automation, software and next-generation sequencing or mass spectrometry workflows. Seer also provides related consumables, instruments, software and services intended to support sample processing, data generation and interpretation.

Seer’s products are used by pharmaceutical and biotechnology companies, academic and research institutions, and other organizations involved in biomedical research. The company was founded in 2017 and is headquartered in Redwood City, California, serving customers in the United States and international markets. Seer is led by co-founder and Chief Executive Officer Omid Ghodsi.

View Seer Profile
Earnings Tools